A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

NCT02181517 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: abicipar pegol
DRUG: ranibizumab
OTHER: sham procedure

Sponsor

Allergan